chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Last week she was having problems in her left arm; Having problems in back of neck, pain goes from one side of the neck to the other; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Last week she was having problems in her left arm) and NECK PAIN (Having problems in back of neck, pain goes from one side of the neck to the other) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2VONS2115) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Last week she was having problems in her left arm) and NECK PAIN (Having problems in back of neck, pain goes from one side of the neck to the other). At the time of the report, PAIN IN EXTREMITY (Last week she was having problems in her left arm) and NECK PAIN (Having problems in back of neck, pain goes from one side of the neck to the other) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Muscular weakness, Vaccination site erythema
Clinical narrative: weakness in both legs; injection site redness; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site redness), HEADACHE (headache), FATIGUE (fatigue) and MUSCULAR WEAKNESS (weakness in both legs) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), HEADACHE (headache) and FATIGUE (fatigue). On 15-Feb-2021, the patient experienced MUSCULAR WEAKNESS (weakness in both legs). At the time of the report, VACCINATION SITE ERYTHEMA (injection site redness), HEADACHE (headache), FATIGUE (fatigue) and MUSCULAR WEAKNESS (weakness in both legs) outcome was unknown.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Burning sensation, Herpes zoster, Pain, Pruritus
Clinical narrative: Shingles; Blisters on back and shoulders; (Rash) Burning; (Rash) Itching; Rash (on back and shoulders); (Rash) Aching; (Rash) Painful; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning) and PRURITUS ((Rash) Itching) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles (The Patient had Shingles before in the1990s.) in 1990.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). In February 2021, the patient experienced RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning), PRURITUS ((Rash) Itching), PAIN ((Rash) Aching) and RASH ((Rash) Painful). At the time of the report, HERPES ZOSTER (Shingles), RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning), PRURITUS ((Rash) Itching), PAIN ((Rash) Aching) and RASH ((Rash) Painful) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Shingles; Blisters on back and shoulders; (Rash) Burning; (Rash) Itching; Rash (on back and shoulders); (Rash) Aching; (Rash) Painful; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles), RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning) and PRURITUS ((Rash) Itching) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Shingles (The Patient had Shingles before in the1990s.) in 1990.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). In February 2021, the patient experienced RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning), PRURITUS ((Rash) Itching), PAIN ((Rash) Aching) and RASH ((Rash) Painful). At the time of the report, HERPES ZOSTER (Shingles), RASH (Rash (on back and shoulders)), BLISTER (Blisters on back and shoulders), BURNING SENSATION ((Rash) Burning), PRURITUS ((Rash) Itching), PAIN ((Rash) Aching) and RASH ((Rash) Painful) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling
Clinical narrative: Swollen; 2 inch wide, 6 inch long red streak down his arm; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness), ERYTHEMA (2 inch wide, 6 inch long red streak down his arm) and PERIPHERAL SWELLING (Swollen) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041220A and 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 13-Feb-2021, the patient experienced ERYTHEMA (2 inch wide, 6 inch long red streak down his arm) and PERIPHERAL SWELLING (Swollen). At the time of the report, PAIN IN EXTREMITY (Arm soreness) had resolved and ERYTHEMA (2 inch wide, 6 inch long red streak down his arm) and PERIPHERAL SWELLING (Swollen) had not resolved.
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of macular rash (bullseye on her arm/huge red circle around the injection site area with bright red dots within it) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included anxiety. Concurrent medical conditions included hypertension and hyperlipidemia. On Feb 4, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced macular rash (bullseye on her arm/huge red circle around the injection site area with bright red dots within it). At the time of the report, macular rash (bullseye on her arm/huge red circle around the injection site area with bright red dots within it) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Bowel movement irregularity, Headache, Malaise, Migraine, Pain in extremity
Clinical narrative: migraine; felt little winded; headache on and off; Fever of 100; soreness in arm; soft bowel movement; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100), PAIN IN EXTREMITY (soreness in arm), BOWEL MOVEMENT IRREGULARITY (soft bowel movement), HEADACHE (headache on and off) and MIGRAINE (migraine) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (Fever of 100), PAIN IN EXTREMITY (soreness in arm), BOWEL MOVEMENT IRREGULARITY (soft bowel movement) and HEADACHE (headache on and off). On an unknown date, the patient experienced MIGRAINE (migraine) and MALAISE (felt little winded). On 12-Feb-2021, PYREXIA (Fever of 100) had resolved. At the time of the report, PAIN IN EXTREMITY (soreness in arm), BOWEL MOVEMENT IRREGULARITY (soft bowel movement) and HEADACHE (headache on and off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: migraine; felt little winded; headache on and off; Fever of 100; soreness in arm; soft bowel movement; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100), PAIN IN EXTREMITY (soreness in arm), BOWEL MOVEMENT IRREGULARITY (soft bowel movement), HEADACHE (headache on and off) and MIGRAINE (migraine) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (Fever of 100), PAIN IN EXTREMITY (soreness in arm), BOWEL MOVEMENT IRREGULARITY (soft bowel movement) and HEADACHE (headache on and off). On an unknown date, the patient experienced MIGRAINE (migraine) and MALAISE (felt little winded). On 12-Feb-2021, PYREXIA (Fever of 100) had resolved. At the time of the report, PAIN IN EXTREMITY (soreness in arm), BOWEL MOVEMENT IRREGULARITY (soft bowel movement) and HEADACHE (headache on and off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose decreased, Headache, Nausea
Clinical narrative: Low blood sugar; Headache; Queasiness; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (Low blood sugar), HEADACHE (Headache) and NAUSEA (Queasiness) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K202A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced BLOOD GLUCOSE DECREASED (Low blood sugar), HEADACHE (Headache) and NAUSEA (Queasiness). At the time of the report, BLOOD GLUCOSE DECREASED (Low blood sugar), HEADACHE (Headache) and NAUSEA (Queasiness) outcome was unknown.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: injection site pain; injection site redness; Injection site swollen; injection site warm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pain), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE WARMTH (injection site warm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013MWA) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (injection site pain), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE WARMTH (injection site warm). At the time of the report, VACCINATION SITE PAIN (injection site pain), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE WARMTH (injection site warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: sore arm; rash; itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), RASH (rash) and PRURITUS (itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), RASH (rash) and PRURITUS (itchy). At the time of the report, PAIN IN EXTREMITY (sore arm), RASH (rash) and PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Swelling on the same arm, neck and shoulder that she got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling on the same arm, neck and shoulder that she got the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced SWELLING (Swelling on the same arm, neck and shoulder that she got the vaccine). At the time of the report, SWELLING (Swelling on the same arm, neck and shoulder that she got the vaccine) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Injection site rash
Clinical narrative: rash 1x1 size near injection site; burning near injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash 1x1 size near injection site) and INJECTION SITE PAIN (burning near injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE RASH (rash 1x1 size near injection site) and INJECTION SITE PAIN (burning near injection site). At the time of the report, INJECTION SITE RASH (rash 1x1 size near injection site) and INJECTION SITE PAIN (burning near injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Fever(100F); Body aches; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever(100F)), MYALGIA (Body aches) and MYALGIA (Muscle pain) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (medical history- no adverse event).   On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced PYREXIA (Fever(100F)), MYALGIA (Body aches) and MYALGIA (Muscle pain). At the time of the report, PYREXIA (Fever(100F)), MYALGIA (Body aches) and MYALGIA (Muscle pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100 (Inconclusive) 100 F.         No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus
Clinical narrative: redness; soreness; itching; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness), PAIN (soreness) and PRURITUS (itching) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (redness), PAIN (soreness) and PRURITUS (itching). At the time of the report, ERYTHEMA (redness), PAIN (soreness) and PRURITUS (itching) outcome was unknown. Not Provided          No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on her chest; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on her chest) in a 58-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.  The patient's past medical history included No adverse event.  On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced RASH (Rash on her chest). At the time of the report, RASH (Rash on her chest) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: ADVERSE SIDE EFFECTS; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (ADVERSE SIDE EFFECTS) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (ADVERSE SIDE EFFECTS). At the time of the report, ADVERSE EVENT (ADVERSE SIDE EFFECTS) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Hiccups
Clinical narrative: hiccups; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HICCUPS (hiccups) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HICCUPS (hiccups). At the time of the report, HICCUPS (hiccups) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Decreased appetite, Dyspnoea, Nausea, Pain
Clinical narrative: Difficulty breathing; Bad Nausea; General body pain- worse in stomach area; Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), NAUSEA (Bad Nausea), PAIN (General body pain- worse in stomach area) and DECREASED APPETITE (Loss of appetite) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DYSPNOEA (Difficulty breathing), NAUSEA (Bad Nausea), PAIN (General body pain- worse in stomach area) and DECREASED APPETITE (Loss of appetite). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at an unspecified dose and frequency; Tylenol at an unspecified dose and frequency and Maalox at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Difficulty breathing), NAUSEA (Bad Nausea), PAIN (General body pain- worse in stomach area) and DECREASED APPETITE (Loss of appetite) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Computerised tomogram: Negative. On 15-Feb-2021, SARS-CoV-1 test: Negative. On 15-Feb-2021, X-ray: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient went to the ER, chest XRAY, COVID 19 test and CT scan were done and they were all negative.  Patient  has taken Tums, Maalox and Extra Strength Tylenol and lots of water however, he is still having all the symptoms
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-1 test, X-ray
Clinical narrative: Difficulty breathing; Bad Nausea; General body pain- worse in stomach area; Loss of appetite; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), NAUSEA (Bad Nausea), PAIN (General body pain- worse in stomach area) and DECREASED APPETITE (Loss of appetite) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DYSPNOEA (Difficulty breathing), NAUSEA (Bad Nausea), PAIN (General body pain- worse in stomach area) and DECREASED APPETITE (Loss of appetite). The patient was treated with CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) at an unspecified dose and frequency; Tylenol at an unspecified dose and frequency and Maalox at an unspecified dose and frequency. At the time of the report, DYSPNOEA (Difficulty breathing), NAUSEA (Bad Nausea), PAIN (General body pain- worse in stomach area) and DECREASED APPETITE (Loss of appetite) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Feb-2021, Computerised tomogram: Negative. On 15-Feb-2021, SARS-CoV-1 test: Negative. On 15-Feb-2021, X-ray: Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient went to the ER, chest XRAY, COVID 19 test and CT scan were done and they were all negative.  Patient  has taken Tums, Maalox and Extra Strength Tylenol and lots of water however, he is still having all the symptoms
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Vaccination site swelling
Clinical narrative: The arm where the vaccine was administered is very swollen; The injection site was very swollen; Injection site has a little itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (The arm where the vaccine was administered is very swollen), INJECTION SITE SWELLING (The injection site was very swollen) and INJECTION SITE PRURITUS (Injection site has a little itchy) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE SWELLING (The arm where the vaccine was administered is very swollen), INJECTION SITE SWELLING (The injection site was very swollen) and INJECTION SITE PRURITUS (Injection site has a little itchy). On 16-Feb-2021, VACCINATION SITE SWELLING (The arm where the vaccine was administered is very swollen), INJECTION SITE SWELLING (The injection site was very swollen) and INJECTION SITE PRURITUS (Injection site has a little itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site warmth, Pain in extremity, Pyrexia
Clinical narrative: high fever 101.3; headache; injection site warm to the touch; fatigue; soreness in my arm; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever 101.3), HEADACHE (headache), INJECTION SITE WARMTH (injection site warm to the touch), FATIGUE (fatigue) and PAIN IN EXTREMITY (soreness in my arm) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included PARACETAMOL, LORAZEPAM, LEVOTHYROXINE, LOSARTAN, FLUOXETINE and DENOSUMAB for an unknown indication.    On 28-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced PYREXIA (high fever 101.3), HEADACHE (headache), INJECTION SITE WARMTH (injection site warm to the touch), FATIGUE (fatigue) and PAIN IN EXTREMITY (soreness in my arm). At the time of the report, PYREXIA (high fever 101.3), HEADACHE (headache), INJECTION SITE WARMTH (injection site warm to the touch), FATIGUE (fatigue) and PAIN IN EXTREMITY (soreness in my arm) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: 101.3 high fever 101.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Side effects of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects of the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effects of the vaccine). At the time of the report, ADVERSE EVENT (Side effects of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: injection site red; injection site started itching; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE PRURITUS (injection site started itching) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE PRURITUS (injection site started itching). At the time of the report, INJECTION SITE ERYTHEMA (injection site red) and INJECTION SITE PRURITUS (injection site started itching) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  No relevant concomitant medications were reported.  No treatment information was provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chest discomfort, Chills, Cough
Clinical narrative: Headache; very ill; feeling as though his sinuses are impacted; chills; Lost sense of smell; Lost sense of taste; Cough; Tightness of chest; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), COUGH (Cough), CHEST DISCOMFORT (Tightness of chest) and PYREXIA (Low grade fever) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Uses albuterol).  On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), COUGH (Cough), CHEST DISCOMFORT (Tightness of chest) and PYREXIA (Low grade fever). On an unknown date, the patient experienced HEADACHE (Headache), MALAISE (very ill), SINUS DISORDER (feeling as though his sinuses are impacted) and CHILLS (chills). At the time of the report, ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), COUGH (Cough), CHEST DISCOMFORT (Tightness of chest), PYREXIA (Low grade fever), HEADACHE (Headache), MALAISE (very ill), SINUS DISORDER (feeling as though his sinuses are impacted) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Negative.   Concomitant medications were not reported.  Treatment includes albuterol and azithromycin.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: Permission to contact.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise, Pyrexia, SARS-CoV-2 test, Sinus disorder
Clinical narrative: Headache; very ill; feeling as though his sinuses are impacted; chills; Lost sense of smell; Lost sense of taste; Cough; Tightness of chest; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), COUGH (Cough), CHEST DISCOMFORT (Tightness of chest) and PYREXIA (Low grade fever) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma (Uses albuterol).  On 12-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), COUGH (Cough), CHEST DISCOMFORT (Tightness of chest) and PYREXIA (Low grade fever). On an unknown date, the patient experienced HEADACHE (Headache), MALAISE (very ill), SINUS DISORDER (feeling as though his sinuses are impacted) and CHILLS (chills). At the time of the report, ANOSMIA (Lost sense of smell), AGEUSIA (Lost sense of taste), COUGH (Cough), CHEST DISCOMFORT (Tightness of chest), PYREXIA (Low grade fever), HEADACHE (Headache), MALAISE (very ill), SINUS DISORDER (feeling as though his sinuses are impacted) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: Negative.   Concomitant medications were not reported.  Treatment includes albuterol and azithromycin.   Most recent FOLLOW-UP information incorporated above includes: On 15-Feb-2021: Permission to contact.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pruritus, Pruritus
Clinical narrative: fatigue; itching at the injection site; aggressive itchiness under the armpit of the vaccinated arm; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (fatigue), INJECTION SITE PRURITUS (itching at the injection site) and PRURITUS (aggressive itchiness under the armpit of the vaccinated arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced FATIGUE (fatigue), INJECTION SITE PRURITUS (itching at the injection site) and PRURITUS (aggressive itchiness under the armpit of the vaccinated arm). On 15-Feb-2021, INJECTION SITE PRURITUS (itching at the injection site) and PRURITUS (aggressive itchiness under the armpit of the vaccinated arm) had resolved. At the time of the report, FATIGUE (fatigue) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment details included Lidocaine cream, Ice and Zyrtec.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Headache, Influenza like illness, Pain in extremity, Swelling
Clinical narrative: turning worst/starting to turn red; left toe was swollen; Sore/(left toe) a lot of pain; Felt like he had the flu; Headache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (left toe was swollen), PAIN IN EXTREMITY (Sore/(left toe) a lot of pain), INFLUENZA LIKE ILLNESS (Felt like he had the flu), HEADACHE (Headache) and ERYTHEMA (turning worst/starting to turn red) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included Gout (Patient have a history of gout.).   On 11-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Felt like he had the flu) and HEADACHE (Headache). On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore/(left toe) a lot of pain). On 13-Feb-2021, the patient experienced SWELLING (left toe was swollen). On an unknown date, the patient experienced ERYTHEMA (turning worst/starting to turn red). At the time of the report, SWELLING (left toe was swollen), PAIN IN EXTREMITY (Sore/(left toe) a lot of pain) and ERYTHEMA (turning worst/starting to turn red) outcome was unknown and INFLUENZA LIKE ILLNESS (Felt like he had the flu) and HEADACHE (Headache) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  Treatment details included Tylenol.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: experiencing itching but not that bad; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (experiencing itching but not that bad) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (experiencing itching but not that bad). At the time of the report, PRURITUS (experiencing itching but not that bad) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dermatitis allergic
Clinical narrative: COVID arm; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ALLERGIC (COVID arm) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Diabetes (PME includes diabetes) since an unknown date. Concurrent medical conditions included Penicillin allergy (Allergies include penicillin). Concomitant products included ACETYLSALICYLIC ACID, METFORMIN and MULTIVITAMIN & MINERAL for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Jan-2021, the patient experienced DERMATITIS ALLERGIC (COVID arm). On 22-Jan-2021, DERMATITIS ALLERGIC (COVID arm) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pain in extremity, Swelling, Vaccination site pain
Clinical narrative: Swelling; Arm painful; Nausea; Vomiting; Redness at injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), PAIN IN EXTREMITY (Arm painful), NAUSEA (Nausea), VOMITING (Vomiting) and VACCINATION SITE PAIN (Redness at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive (I was Covid positive about 90 days ago even was positive in December.). Concomitant products included VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced SWELLING (Swelling), PAIN IN EXTREMITY (Arm painful), NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE PAIN (Redness at injection site) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SWELLING (Swelling), PAIN IN EXTREMITY (Arm painful), NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE PAIN (Redness at injection site) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Cholesterol Medication, High Blood Pressure Medication for drug use for unknown indication.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 and included events outcome  information.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Swelling; Arm painful; Nausea; Vomiting; Redness at injection site; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), PAIN IN EXTREMITY (Arm painful), NAUSEA (Nausea), VOMITING (Vomiting) and VACCINATION SITE PAIN (Redness at injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive (I was Covid positive about 90 days ago even was positive in December.). Concomitant products included VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced SWELLING (Swelling), PAIN IN EXTREMITY (Arm painful), NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE PAIN (Redness at injection site) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SWELLING (Swelling), PAIN IN EXTREMITY (Arm painful), NAUSEA (Nausea), VOMITING (Vomiting), VACCINATION SITE PAIN (Redness at injection site) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were Cholesterol Medication, High Blood Pressure Medication for drug use for unknown indication.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 and included events outcome  information.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Injection site erythema, Injection site pruritus, Pain in extremity, Tenderness
Clinical narrative: red circle around the injection site, size necklet; itchy at the injection site; hard to touch; tender; arm hurt really bad; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt really bad), TENDERNESS (tender), INJECTION SITE PRURITUS (itchy at the injection site), FEELING ABNORMAL (hard to touch) and INJECTION SITE ERYTHEMA (red circle around the injection site, size necklet) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M2014) for COVID-19 vaccination.     The patient's past medical history included Guillain-Barre syndrome. Concomitant products included LEVOTHYROXINE SODIUM (THYROXINE), EZETIMIBE, DOCUSATE SODIUM (STOOL SOFTENER), VITAMIN D3 and MACROGOL 3350 (MIRALAX).   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurt really bad). On 08-Feb-2021, the patient experienced TENDERNESS (tender). On 15-Feb-2021, the patient experienced INJECTION SITE PRURITUS (itchy at the injection site) and FEELING ABNORMAL (hard to touch). On 16-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (red circle around the injection site, size necklet). At the time of the report, PAIN IN EXTREMITY (arm hurt really bad), TENDERNESS (tender), INJECTION SITE PRURITUS (itchy at the injection site), FEELING ABNORMAL (hard to touch) and INJECTION SITE ERYTHEMA (red circle around the injection site, size necklet) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site joint swelling, Injection site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of injection site pain (arm sore after the injection) and injection site joint swelling (bright pink circle around the injection site about 1 inch in diameter) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 038K20A) for COVID-19 immunization. No medical history reported. On Feb 5, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced injection site pain (arm sore after the injection) and injection site joint swelling (bright pink circle around the injection site about 1 inch in diameter). At the time of the report, injection site pain (arm sore after the injection) and injection site joint swelling (bright pink circle around the injection site about 1 inch in diameter) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Products known to have been used by the patient within two weeks prior to the event, not reported. Treatment information not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Red rash on arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red rash on arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced RASH ERYTHEMATOUS (Red rash on arm). At the time of the report, RASH ERYTHEMATOUS (Red rash on arm) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.   Treatment was not specified.   This case was linked to MOD-2021-015381 (Patient Link).
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Joint stiffness, Myalgia
Clinical narrative: Very stiff joints; Muscle aches; Fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of JOINT STIFFNESS (Very stiff joints), MYALGIA (Muscle aches) and FATIGUE (Fatigue) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced JOINT STIFFNESS (Very stiff joints), MYALGIA (Muscle aches) and FATIGUE (Fatigue). At the time of the report, JOINT STIFFNESS (Very stiff joints), MYALGIA (Muscle aches) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.